DTT Journal & Abstracts
Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics is the official journal of ATTD.
Led by Editor-in-Chief Satish K. Garg, MD, Diabetes Technology & Therapeutics is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems and software for managing patients with diabetes.
This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care.
Abstracts from the ATTD 2022 Conference
To view the ATTD 2022 Journal, click here.
To view the ATTD 2022 Journal supported late breaking abstracts supplement, please click here.
Abstracts published at the ATTD Conference
- To view the ATTD 2021 Abstracts published in the DTT Journal, click here to download (pdf file)
- To view the ATTD 2020 Abstracts published in the DTT Journal click here to download (pdf file)
- To view the ATTD 2019 Abstracts published in the DTT Journal click here to download (pdf file)
- To view the ATTD 2018 Abstracts published in the DTT Journal click here to download (pdf file)
- To view the ATTD 2017 Abstracts published in the DTT Journal click here to download (pdf file)
Special Subscription Rates for ATTD Attendees
Save over 85% on your personal online subscription!
Visit the DTT website and enter group code ATTD.